SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,602,425 | -40.5% | 2,294,095 | -23.4% | 0.11% | -26.5% |
| Q4 2022 | $2,693,662 | -85.7% | 2,992,958 | -4.8% | 0.15% | -84.0% |
| Q3 2022 | $18,858,000 | +44.9% | 3,142,958 | 0.0% | 0.94% | +40.9% |
| Q2 2022 | $13,012,000 | +9.0% | 3,142,958 | 0.0% | 0.67% | +93.6% |
| Q1 2022 | $11,943,000 | -15.6% | 3,142,958 | 0.0% | 0.34% | +20.6% |
| Q4 2021 | $14,143,000 | -3.4% | 3,142,958 | 0.0% | 0.29% | +64.4% |
| Q3 2021 | $14,646,000 | -33.9% | 3,142,958 | 0.0% | 0.17% | -39.8% |
| Q2 2021 | $22,158,000 | +25.1% | 3,142,958 | +4.8% | 0.29% | -27.4% |
| Q1 2021 | $17,716,000 | – | 2,997,682 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |